Literature DB >> 34232465

TCF7L2 gene polymorphism as a risk for type 2 diabetes mellitus and diabetic microvascular complications.

Noran Talaat Aboelkhair1, Heba Elsayed Kasem2, Amera Anwar Abdelmoaty3, Rawhia Hassan El-Edel4.   

Abstract

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic condition with various genetics and environmental influences that affects the capacity of the body to produce or use insulin resulting in hyperglycemia, which may lead to variable complications. It is one of the world's rising health problems. There is emerging evidence that some genetic polymorphisms can impact the risk of evolving T2DM. We try to determine the relationship of (rs7903146) variant of the Transcription factor 7-like 2 (TCF7L2) gene with T2DM and its microvascular complications. METHODS AND
RESULTS: This case-control study included 180 subjects: 60 diabetic patients without complications, 60 diabetic patients with microvascular complications and 60 matched healthy controls. Genotypes of rs7903146 (C/T) SNP in the TCF7L2 gene were evaluated by real-time polymerase chain reaction via TaqMan allelic discrimination. Logistic regression was used to detect the most independent factor for development of diabetes and diabetic microvascular complications. Variant homozygous TT and heterozygous CT genotypes were significantly increased in diabetic without complications and diabetic with complications groups than controls (p = 0.003, 0.001) respectively. The T allele was more represented in both patient groups than controls with no significant difference between patient groups. TT genotype as well as T allele was significantly associated with increased T2DM risk.
CONCLUSION: The T allele of rs7903146 polymorphism of TCF7L2 confers susceptibility to development of T2DM. However, no significant association was found for diabetic complications.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Microvascular complications; TCF7L2; Type 2 diabetes; rs7903146

Mesh:

Substances:

Year:  2021        PMID: 34232465     DOI: 10.1007/s11033-021-06537-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  2 in total

1.  Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.

Authors:  Mahmoud Emara; Rawhia El-Edel; Waleed M Fathy; Noran T Aboelkhair; Mona M Watany; Dalia H Abou-Elela
Journal:  Mediators Inflamm       Date:  2020-07-01       Impact factor: 4.711

2.  Association of Glycated Haemoglobin and Serum Apolipoproteins with Diabetic Retinopathy: An Indian Overview.

Authors:  Bhasker Mukherjee; Sandeep Shankar; Rehan Ahmed; Kanchan Singh; Kapil Bhatia
Journal:  J Clin Diagn Res       Date:  2017-09-01
  2 in total
  3 in total

1.  Association of genetic polymorphisms of PCSK9 with type 2 diabetes in Uygur Chinese population.

Authors:  Meng-Meng Wang; Chen-Fei Lu; Shi-Qi Yan; Bao-Zhu Wang; Gulinazi Yesitayi; Yong-Liang Tian; Yi-Tong Ma
Journal:  BMC Cardiovasc Disord       Date:  2022-06-22       Impact factor: 2.174

2.  Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions.

Authors:  Alessandro Ottaiano; Luisa Circelli; Mariachiara Santorsola; Giovanni Savarese; Daniela Fontanella; Valerio Gigantino; Annabella Di Mauro; Maurizio Capuozzo; Silvia Zappavigna; Angela Lombardi; Francesco Perri; Marco Cascella; Vincenza Granata; Maurizio Capuozzo; Guglielmo Nasti; Michele Caraglia
Journal:  Mol Oncol       Date:  2021-11-19       Impact factor: 6.603

Review 3.  Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus.

Authors:  Hideaki Kaneto; Tomohiko Kimura; Masashi Shimoda; Atsushi Obata; Junpei Sanada; Yoshiro Fushimi; Taka-Aki Matsuoka; Kohei Kaku
Journal:  Biomedicines       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.